Xanthohumol Suppresses NPC1L1 Gene Expression through Downregulation of HNF-4 alpha( )and Inhibits Cholesterol Uptake in Caco-2 Cells

doi:10.1021/acs.jafc.9b05221

CNU IR > Pharmacy and Science > Dept. of Biotechnology (including master's program) > Periodical Articles > Item 310902800/32669

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/32669

Title:	Xanthohumol Suppresses NPC1L1 Gene Expression through Downregulation of HNF-4 alpha( )and Inhibits Cholesterol Uptake in Caco-2 Cells
Authors:	Thang, Sang Kim Chen, Pei-Yi Gao, Wan-Yun Wu, Ming-Jiuan Pan, Min-Hsiung Yen, Jui-Hung
Contributors:	Tzu Chi Univ, Inst Med Sci Hualien Tzu Chi Hosp, Buddhist Tzu Chi Fdn, Ctr Med Genet Tzu Chi Univ, Dept Mol Biol & Human Genet Chia Nan Univ Pharm & Sci, Dept Biotechnol Natl Taiwan Univ, Inst Food Sci & Technol
Keywords:	xanthohumol cholesterol absorption NPC1L1 HNF-4 alpha statin
Date:	2019
Issue Date:	2020-07-29 13:54:32 (UTC+8)
Publisher:	AMER CHEMICAL SOC
Abstract:	Xanthohumol (Xan) is a prenylated chalcone mainly found in hops; it has been demonstrated to function against hypercholesterolemia, hyperlipidemia, and atherosclerosis. In this study, we focused on the hypocholesterolemic effect of Xan on cholesterol uptake and the underlying molecular mechanisms of Xan in human intestinal Caco-2 cells. The microarray data showed that Niemann-Pick C1-like 1 (NPC1L1), an essential transporter for dietary cholesterol absorption, was significantly downregulated in Xan-treated Caco-2 cells. We demonstrated that Xan (10 and 20 mu M) suppressed the mRNA and protein expression of NPC1L1 by 0.65 +/- 0.12-fold and 0.54 +/- 0.15-fold and 0.72 +/- 0.04-fold and 0.44 +/- 0.12-fold, respectively, compared to that of the vehicle-treated Caco-2 cells. Moreover, Xan (10 and 20 mu M) significantly inhibited cholesterol uptake by approximately 12 and 32% in Caco-2 cells. NPC1L1 promoter activity was significantly suppressed by Xan, and a DNA element within the NPC1L1 promoter involved in Xan-mediated NPC1L1 reduction located between the -120 and -20 positions was identified. Moreover, Xan markedly decreased the mRNA and protein levels of hepatocyte nuclear factor 4 alpha (HNF-4 alpha), a critical activator of NPC1L1 transcription, and subsequently attenuated HNF-4 alpha/NPC1L1 promoter complex formation, resulting in the suppression of NPC1L1 gene expression. Finally, we demonstrated that Xan markedly abolished lovastatin-induced NPC1L1 overexpression in Caco-2 cells. These findings reveal that Xan suppresses NPC1L1 expression via downregulation of HNF-4 alpha and exerts inhibitory effects on cholesterol uptake in the intestinal Caco-2 cells. Our findings suggest Xan could serve as a potential cholesterol-lowering agent and supplement for statin therapy.
Relation:	Journal of Agricultural and Food Chemistry, v.67, n.40, pp.
Appears in Collections:	[Dept. of Biotechnology (including master's program)] Periodical Articles

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	1233	View/Open

Loading...